M84.550D Pathological fracture in neoplastic disease, pelvis, subsequent encounter for fracture with routine healing

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Pelvis, Subsequent Encounter for Fracture with Routine Healing (ICD-10-CM: M84.550D)

Summary

This condition describes a bone fracture occurring in the pelvis due to underlying neoplastic (cancerous) disease, with the fracture in a subsequent encounter phase and routine healing. The fracture results from weakened bone structure caused by cancer, rather than direct trauma. It is a complication of malignancy affecting pelvic bone integrity, where the fracture is being managed in a follow-up setting with expected normal healing progression.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy pelvic bone tissue, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode the pelvis, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the pelvis.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to pelvic sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often without obvious injury.
• Swelling, bruising, or visible deformity in the affected pelvic area.
• Difficulty bearing weight or limited mobility.
• Persistent pain during routine healing follow-up.

Diagnosis

Diagnosis involves clinical evaluation of pelvic pain and fracture history, combined with imaging (e.g., X-ray, CT, or MRI) to confirm the fracture and underlying neoplastic cause. Laboratory tests may assess cancer markers or bone health. Documentation must specify the pelvic site, neoplastic origin, and subsequent encounter status with routine healing.

Treatment Options

Treatment focuses on stabilizing the fracture (e.g., bracing, surgery) and managing the underlying cancer. Pain management, physical therapy, and monitoring for healing are standard. Oncologic care (e.g., chemotherapy, radiation) addresses the neoplastic disease to prevent further bone damage.

Prognosis and Follow-Up

Prognosis depends on the underlying cancer type, extent of bone involvement, and treatment response. Routine healing is expected in subsequent encounters, but ongoing monitoring for recurrence or complications is necessary. Follow-up imaging and clinical assessments track healing progress and cancer status.

Complications

• Delayed or non-union of the fracture.
• Infection at the fracture site.
• Progression of the underlying neoplastic disease.
• Chronic pain or functional impairment.

Lifestyle & Prevention

• Maintain bone health through calcium and vitamin D intake (if appropriate).
• Avoid high-impact activities that stress the pelvis.
• Follow oncologic treatment plans to control cancer-related bone damage.
• Use assistive devices (e.g., walkers) to reduce weight-bearing stress during healing.

When to Seek Professional Help

Seek care if pain worsens, swelling increases, or mobility declines during healing. New or worsening symptoms (e.g., fever, unexplained weight loss) may indicate infection or cancer progression and require prompt evaluation.

Tips for Medical Coders

Document the pelvic site, neoplastic origin, and subsequent encounter status with routine healing. Ensure clinical notes specify fracture healing progress and exclude acute or delayed healing phases. Code M84.550D applies only when the fracture is in a subsequent encounter with routine healing; acute or non-routine healing requires different coding.